Company / Cash & Equivalents
ULTRALIFE CORP Cash & Equivalents History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$6.9M
FY2024
5-year range
$5.6M / $10.2M
FY2020-FY2024
Trend
-32.8%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash & Equivalents has fluctuated over the past 7 years, ranging from $6M in FY2022 to $18M in FY2018.
Based on SEC 10-K filings.
$7M in FY2024 with a 5-year CAGR of -0.8%.
Improved from $6M to $7M over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -6.3%
- 5-Year CAGR
- -0.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -0.8%, indicating a declining trend.
- In FY2024, cash & equivalents decreased 32.8% year-over-year.
- Peak cash & equivalents was recorded in FY2018.
- Lowest cash & equivalents in the period was in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $6.9M | -32.8% |
| FY2023 | $10.2M | +81.0% |
| FY2022 | $5.6M | -32.4% |
| FY2021 | $8.3M | -21.1% |
| FY2020 | $10.6M | +48.0% |
| FY2019 | $7.1M | -60.9% |
| FY2018 | $18.2M | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026